TRPM7 controls mesenchymal features of breast cancer cells by tensional regulation of SOX4

Mechanically induced signaling pathways are important drivers of tumor progression. However, if and how mechanical signals affect metastasis or therapy response remains poorly understood. We previously found that the channel-kinase TRPM7, a regulator of cellular tension implicated in mechano-sensory...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 1864; no. 7; pp. 2409 - 2419
Main Authors Kuipers, Arthur J., Middelbeek, Jeroen, Vrenken, Kirsten, Pérez-González, Carlos, Poelmans, Geert, Klarenbeek, Jeffrey, Jalink, Kees, Trepat, Xavier, van Leeuwen, Frank N.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.07.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mechanically induced signaling pathways are important drivers of tumor progression. However, if and how mechanical signals affect metastasis or therapy response remains poorly understood. We previously found that the channel-kinase TRPM7, a regulator of cellular tension implicated in mechano-sensory processes, is required for breast cancer metastasis in vitro and in vivo. Here, we show that TRPM7 contributes to maintaining a mesenchymal phenotype in breast cancer cells by tensional regulation of the EMT transcription factor SOX4. The functional consequences of SOX4 knockdown closely mirror those produced by TRPM7 knockdown. By traction force measurements, we demonstrate that TRPM7 reduces cytoskeletal tension through inhibition of myosin II activity. Moreover, we show that SOX4 expression and downstream mesenchymal markers are inversely regulated by cytoskeletal tension and matrix rigidity. Overall, our results identify SOX4 as a transcription factor that is uniquely sensitive to cellular tension and indicate that TRPM7 may contribute to breast cancer progression by tensional regulation of SOX4. •TRPM7 is a cation channel implicated in regulation of breast cancer plasticity.•TRPM7 reduces cytoskeletal tension by inhibition of myosin II activity.•Expression of the EMT transcription factor SOX4 is subject to regulation by actomyosin based cellular tension.•TRPM7 may contribute to breast cancer progression by tensional regulation of SOX4.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0925-4439
0006-3002
1879-260X
DOI:10.1016/j.bbadis.2018.04.017